Therefore, GOT1-mediated glutamate metabolism might be critical for PCa disease progression, and a better understanding of GOT1-driven metabolism could reveal potential drug targets and biomarkers for PCa. The gene discussed is GOT1; the disease is posterior cortical atrophy.